These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1244 related items for PubMed ID: 23814096

  • 1. Prevalence of polycystic ovary syndrome in women in China: a large community-based study.
    Li R, Zhang Q, Yang D, Li S, Lu S, Wu X, Wei Z, Song X, Wang X, Fu S, Lin J, Zhu Y, Jiang Y, Feng HL, Qiao J.
    Hum Reprod; 2013 Sep; 28(9):2562-9. PubMed ID: 23814096
    [Abstract] [Full Text] [Related]

  • 2. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.
    Zhang HY, Guo CX, Zhu FF, Qu PP, Lin WJ, Xiong J.
    Arch Gynecol Obstet; 2013 Mar; 287(3):525-31. PubMed ID: 23108387
    [Abstract] [Full Text] [Related]

  • 3. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A.
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [Abstract] [Full Text] [Related]

  • 4. [Epidemiological study of clinical characteristics of Chinese Han ethnic women with polycystic ovary syndrome].
    Zhao JL, Chen ZJ, Zhao LX, Geng L, Wang S, Gao SS, Zhang P, Liu S, Zhou FR.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):375-9. PubMed ID: 16831357
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome.
    Liang P, Xi L, Shi J, Li W, Zhao S, Deng Y, Wang R, Sun Y, Gu B, Yuan L, Zhang Y, Gu W, Wang W, Hong J.
    Fertil Steril; 2017 Apr; 107(4):1048-1054. PubMed ID: 28238496
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J, Fan P, Liu H, Bai H, Wang Y, Zhang F.
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [Abstract] [Full Text] [Related]

  • 7. Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome.
    Kim JJ, Hwang KR, Chae SJ, Yoon SH, Choi YM.
    Hum Reprod; 2020 Mar 27; 35(3):652-659. PubMed ID: 32211797
    [Abstract] [Full Text] [Related]

  • 8. Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guideline.
    Kim JJ, Hwang KR, Lee D, Kim S, Choi YM.
    Hum Reprod; 2024 May 02; 39(5):1072-1077. PubMed ID: 38514450
    [Abstract] [Full Text] [Related]

  • 9. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
    Farhadi-Azar M, Behboudi-Gandevani S, Rahmati M, Mahboobifard F, Khalili Pouya E, Ramezani Tehrani F, Azizi F.
    Front Endocrinol (Lausanne); 2022 May 02; 13():825528. PubMed ID: 35299965
    [Abstract] [Full Text] [Related]

  • 10. Epidemiologic investigation of polycystic ovarian syndrome (PCOS) in Han ethnic women of reproductive age in Liaoning Province, China.
    Jiao J, Fang Y, Wang T, Wang Z, Zhou M, Wang X.
    Clin Exp Obstet Gynecol; 2014 May 02; 41(3):304-9. PubMed ID: 24992782
    [Abstract] [Full Text] [Related]

  • 11. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME, Jarrett BY, Brooks ED, Reines JK, Peppin AK, Muhn N, Haider E, Pierson RA, Chizen DR.
    Hum Reprod; 2013 May 02; 28(5):1361-8. PubMed ID: 23503943
    [Abstract] [Full Text] [Related]

  • 12. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
    West S, Lashen H, Bloigu A, Franks S, Puukka K, Ruokonen A, Järvelin MR, Tapanainen JS, Morin-Papunen L.
    Hum Reprod; 2014 Oct 10; 29(10):2339-51. PubMed ID: 25085801
    [Abstract] [Full Text] [Related]

  • 13. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

  • 14. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran.
    Tehrani FR, Rashidi H, Khomami MB, Tohidi M, Azizi F.
    Reprod Biol Endocrinol; 2014 Sep 16; 12():89. PubMed ID: 25224635
    [Abstract] [Full Text] [Related]

  • 15. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
    Panidis D, Tziomalos K, Macut D, Delkos D, Betsas G, Misichronis G, Katsikis I.
    Fertil Steril; 2012 Feb 16; 97(2):494-500. PubMed ID: 22192350
    [Abstract] [Full Text] [Related]

  • 16. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
    Skiba MA, Bell RJ, Herbert D, Garcia AM, Islam RM, Davis SR.
    Hum Reprod; 2021 May 17; 36(6):1611-1620. PubMed ID: 33846715
    [Abstract] [Full Text] [Related]

  • 17. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
    Panidis D, Tziomalos K, Misichronis G, Papadakis E, Betsas G, Katsikis I, Macut D.
    Hum Reprod; 2012 Feb 17; 27(2):541-9. PubMed ID: 22144419
    [Abstract] [Full Text] [Related]

  • 18. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
    Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO.
    Hum Reprod; 2016 Dec 17; 31(12):2841-2855. PubMed ID: 27664216
    [Abstract] [Full Text] [Related]

  • 19. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
    Pinola P, Lashen H, Bloigu A, Puukka K, Ulmanen M, Ruokonen A, Martikainen H, Pouta A, Franks S, Hartikainen AL, Järvelin MR, Morin-Papunen L.
    Hum Reprod; 2012 Nov 17; 27(11):3279-86. PubMed ID: 22933528
    [Abstract] [Full Text] [Related]

  • 20. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
    Azziz R, Kintziger K, Li R, Laven J, Morin-Papunen L, Merkin SS, Teede H, Yildiz BO.
    Hum Reprod; 2019 Nov 01; 34(11):2254-2265. PubMed ID: 31751476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.